Trial Profile
Effect of Ivabradine on heart rate as well as on clinical and haemodynamic recovery in patients with acute ischemic heart failure.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- 22 Nov 2016 Primary end point (Cardiovascular death or hospital admission for worsening heart failure) has not been mate.
- 22 Nov 2016 New trial record